Switching GLP-1 Medicines Charleston SC - What Changes and Why | Hope Integrative Medicine
October 31, 2026 · 1:11
Which GLP-1s are the same medicine under different names, what changes when you switch between semaglutide and tirzepatide, and why you should not convert doses yourself.
Looking for a Primary Care Provider?
Checkups, preventive care and ongoing care for chronic conditions in West Ashley, Charleston. New patients are often able to be scheduled within a week of requesting an appointment. Schedule an appointment today.
Transcript
Switching GLP-1 medicines: what changes, and what stays the same. Here are three things to know. Ozempic and Wegovy are both semaglutide, made by Novo Nordisk, though their dose steps differ and Wegovy goes higher. Mounjaro and Zepbound are both tirzepatide, made by Eli Lilly, with the same dose steps. Which brand your insurance covers usually depends on your diagnosis, not the medicine itself. Moving from semaglutide to tirzepatide is a true change. There is no official dose conversion between them, so your prescriber chooses a starting dose based on how you did on the current one, your side effects and your goals, and usually works up from there. If you have been off a GLP-1 for more than a couple of weeks, restarting at your old dose can bring back strong nausea and vomiting. Many people need to restart lower and step back up. Dose charts online often mix up products and pens, so let your prescriber write the switch. Read the full article at hopeintegrativemed.com.
Frequently Asked Questions
Common reasons include insurance coverage changes, side effects or a plateau in results. Some switches are simpler than they sound, and others need real care.
Semaglutide, sold as Ozempic and Wegovy, is made by Novo Nordisk. Tirzepatide, sold as Mounjaro and Zepbound, is made by Eli Lilly. All four are weekly injections.
Wegovy's approvals include weight management and lowering heart risk in people with heart disease. Ozempic, the same medicine, is approved for type 2 diabetes.
